Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clearance Models: Noncompartmental Models01:17

Clearance Models: Noncompartmental Models

331
Clearance is a pharmacokinetic parameter traditionally defined by compartment models, signifying the rate at which a drug is expelled from the body. However, a noncompartmental model offers an alternative method for assessing clearance, primarily employing empirical data obtained after administering a single drug dose.
The noncompartmental approach capitalizes on extensive sampling data, correlating the volume of distribution to systemic exposure and the administered dosage. This method enables...
331
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

434
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
434
Clearance Models: Compartment Models01:25

Clearance Models: Compartment Models

1.6K
Clearance measures drug elimination from the central compartment, including plasma and highly perfused organs like kidneys and liver. Its calculation varies depending on pharmacokinetic models and administration routes. The one-compartment model, for instance, portrays the pharmacokinetics of polar drugs such as aminoglycoside antibiotics administered intravenously and readily excreted in urine. In this case, clearance is influenced by the terminal rate constant (λz) and the total volume...
1.6K
Drug Clearance: Overview01:06

Drug Clearance: Overview

516
Drug elimination refers to drug removal from the body, either through urine or bile, by the kidneys or liver, respectively. A pharmacokinetic parameter, drug clearance, measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the drug's concentration in plasma.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination, including...
516
Drug Elimination: The Concept of Clearance01:06

Drug Elimination: The Concept of Clearance

4.2K
Drug elimination refers to removing drugs from the body, either through urine by the kidneys or through bile by the liver. Drug clearance is a pharmacokinetic parameter that measures the efficiency of drug removal from the bloodstream within a specific time frame. It is calculated as the rate at which a drug is eliminated from plasma divided by the plasma concentration of the drug.
Drug clearance is not limited to renal excretion but encompasses all organs involved in drug elimination,...
4.2K
Renal Drug Clearance: Comparison Between Renal Excretion Methods01:08

Renal Drug Clearance: Comparison Between Renal Excretion Methods

726
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
726

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe asthma and remission prospects in Europe (SHARP): insights from a multicentre observational study based on the European Severe Asthma Registry.

The Lancet. Respiratory medicine·2026
Same author

No association between troponin and COPD without cardiovascular influence: findings from a population-based cohort (SCAPIS).

Thorax·2026
Same author

Multimorbidity phenotypes and associated characteristics in severe asthma: an observational study of European severe asthma registries.

The Lancet regional health. Europe·2026
Same author

Corrigendum to "Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS" [Respir. Med. 249 (2025) 108463-108463].

Respiratory medicine·2026
Same author

Plasma proteins associated with cardiovascular disease in relation to lung function in SCAPIS.

Respiratory medicine·2025
Same author

Mitochondrial DNA via recipient TLR9 acts as a potent first hit in murine transfusion-related acute lung injury.

Blood·2025

Related Experiment Video

Updated: Mar 10, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
09:09

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

Published on: November 16, 2016

8.4K

Intracellular Clearance by Nobel Laureates

Heiko Herwald, Arne Egesten

    Journal of Innate Immunity
    |December 7, 2016
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
    18:57

    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

    Published on: October 17, 2013

    47.6K
    Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
    06:14

    Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

    Published on: May 8, 2018

    9.3K

    Related Experiment Videos

    Last Updated: Mar 10, 2026

    High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
    09:09

    High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity

    Published on: November 16, 2016

    8.4K
    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
    18:57

    Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers

    Published on: October 17, 2013

    47.6K
    Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
    06:14

    Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue

    Published on: May 8, 2018

    9.3K